Literature DB >> 28448020

Analysis of Lymphocyte Extravasation Using an In Vitro Model of the Human Blood-brain Barrier.

Andreas Schulte-Mecklenbeck1, Urvashi Bhatia1, Tilman Schneider-Hohendorf1, Nicholas Schwab1, Heinz Wiendl1, Catharina C Gross2.   

Abstract

Lymphocyte extravasation into the central nervous system (CNS) is critical for immune surveillance. Disease-related alterations of lymphocyte extravasation might result in pathophysiological changes in the CNS. Thus, investigation of lymphocyte migration into the CNS is important to understand inflammatory CNS diseases and to develop new therapy approaches. Here we present an in vitro model of the human blood-brain barrier to study lymphocyte extravasation. Human brain microvascular endothelial cells (HBMEC) are confluently grown on a porous polyethylene terephthalate transwell insert to mimic the endothelium of the blood-brain barrier. Barrier function is validated by zonula occludens immunohistochemistry, transendothelial electrical resistance (TEER) measurements as well as analysis of evans blue permeation. This model allows investigation of the diapedesis of rare lymphocyte subsets such as CD56brightCD16dim/- NK cells. Furthermore, the effects of other cells, cytokines and chemokines, disease-related alterations, and distinct treatment regimens on the migratory capacity of lymphocytes can be studied. Finally, the impact of inflammatory stimuli as well as different treatment regimens on the endothelial barrier can be analyzed.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28448020      PMCID: PMC5564469          DOI: 10.3791/55390

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  47 in total

Review 1.  Junctional complexes of the blood-brain barrier: permeability changes in neuroinflammation.

Authors:  Margaret A Petty; Eng H Lo
Journal:  Prog Neurobiol       Date:  2002-12       Impact factor: 11.685

2.  A dynamic in vitro BBB model for the study of immune cell trafficking into the central nervous system.

Authors:  Luca Cucullo; Nicola Marchi; Mohammed Hossain; Damir Janigro
Journal:  J Cereb Blood Flow Metab       Date:  2010-09-15       Impact factor: 6.200

Review 3.  Disruption of central nervous system barriers in multiple sclerosis.

Authors:  Jorge Ivan Alvarez; Romain Cayrol; Alexandre Prat
Journal:  Biochim Biophys Acta       Date:  2010-07-07

4.  Dimethylfumarate reduces leukocyte rolling in vivo through modulation of adhesion molecule expression.

Authors:  Simone A Rubant; Ralf J Ludwig; Sandra Diehl; Katja Hardt; Roland Kaufmann; Josef M Pfeilschifter; Wolf-Henning Boehncke
Journal:  J Invest Dermatol       Date:  2007-08-02       Impact factor: 8.551

5.  Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation.

Authors:  Catharina C Gross; Andreas Schulte-Mecklenbeck; Anna Rünzi; Tanja Kuhlmann; Anita Posevitz-Fejfár; Nicholas Schwab; Tilman Schneider-Hohendorf; Sebastian Herich; Kathrin Held; Matea Konjević; Marvin Hartwig; Klaus Dornmair; Reinhard Hohlfeld; Tjalf Ziemssen; Luisa Klotz; Sven G Meuth; Heinz Wiendl
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-09       Impact factor: 11.205

Review 6.  Multiple sclerosis therapeutics: unexpected outcomes clouding undisputed successes.

Authors:  Heinz Wiendl; Reinhard Hohlfeld
Journal:  Neurology       Date:  2009-03-17       Impact factor: 9.910

7.  Evidence for an accessory role of LFA-1 in lymphocyte-high endothelium interaction during homing.

Authors:  A Hamann; D Jablonski-Westrich; A Duijvestijn; E C Butcher; H Baisch; R Harder; H G Thiele
Journal:  J Immunol       Date:  1988-02-01       Impact factor: 5.422

Review 8.  Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke.

Authors:  Melissa A Lopes Pinheiro; Gijs Kooij; Mark R Mizee; Alwin Kamermans; Gaby Enzmann; Ruth Lyck; Markus Schwaninger; Britta Engelhardt; Helga E de Vries
Journal:  Biochim Biophys Acta       Date:  2015-10-23

9.  VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells.

Authors:  Tilman Schneider-Hohendorf; Jan Rossaint; Hema Mohan; Daniel Böning; Johanna Breuer; Tanja Kuhlmann; Catharina C Gross; Ken Flanagan; Lydia Sorokin; Dietmar Vestweber; Alexander Zarbock; Nicholas Schwab; Heinz Wiendl
Journal:  J Exp Med       Date:  2014-08-18       Impact factor: 14.307

10.  Trafficking of lymphocytes into the CNS.

Authors:  Nicholas Schwab; Tilman Schneider-Hohendorf; Heinz Wiendl
Journal:  Oncotarget       Date:  2015-07-20
View more
  1 in total

1.  Raised SPINK1 levels play a role in angiogenesis and the transendothelial migration of ALL cells.

Authors:  Dong Luo; Dongqiang Liu; Chunbao Rao; Shanshan Shi; Xiaomei Zeng; Sha Liu; Hua Jiang; Lishi Liu; Zhenhong Zhang; Xiaomei Lu
Journal:  Sci Rep       Date:  2022-02-22       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.